Tissue Sample Collection From Patients With Fanconi Anemia
Parole chiave
Astratto
Descrizione
OBJECTIVES:
- Acquire rare solid tumor samples from patients with Fanconi anemia in order to create a Fanconi Anemia Cell Repository at the Oregon Health and Science University Cancer Institute.
- Study repository tissue using a variety of molecular methods, including gene microarrays.
- Develop cancer cell lines that are publicly available from tissue archived from patients with Fanconi anemia.
OUTLINE: Tumor biopsies are collected from patients with Fanconi anemia and archived for future molecular studies, cell line generation, and general usage by the research community at large. Medical information about the patient's cancer is also archived.
PROJECTED ACCRUAL: Not specified.
Date
| Ultimo verificato: | 10/31/2017 |
| Primo inviato: | 05/08/2009 |
| Iscrizione stimata inviata: | 05/08/2009 |
| Primo pubblicato: | 05/11/2009 |
| Ultimo aggiornamento inviato: | 11/29/2017 |
| Ultimo aggiornamento pubblicato: | 12/03/2017 |
| Data di inizio effettiva dello studio: | 07/31/2005 |
| Data di completamento primaria stimata: | 02/28/2013 |
| Data stimata di completamento dello studio: | 04/30/2013 |
Condizione o malattia
Intervento / trattamento
Other: biologic sample preservation procedure
Procedure: biopsy
Fase
Criteri di idoneità
| Età idonea per lo studio | 1 Year Per 1 Year |
| Sessi idonei allo studio | All |
| Metodo di campionamento | Probability Sample |
| Accetta volontari sani | sì |
| Criteri | DISEASE CHARACTERISTICS: - Confirmed Fanconi anemia - Confirmed malignant solid tumor - Biopsy of tumor tissue available PATIENT CHARACTERISTICS: - Not specified PRIOR CONCURRENT THERAPY: - Not specified |
Risultato
Misure di esito primarie
1. Creation of a Fanconi Anemia Cell Repository using rare solid tumor samples from patients with Fanconi anemia [Duration of the study]
2. Study tissue samples by molecular methods, including gene microarrays [Duration of the study]
3. Development of cancer cell lines from tissue archived from patients with Fanconi anemia [Duration of the study]
